Sponsored by Experimental Biology

Feng Zhang, PhD
Harnessing Nature's Diversity for Gene Editing and Beyond

The Tang Prize in Biopharmaceutical Science recognizes original biopharmaceutical or biomedical research that has led to significant advances towards preventing, diagnosing and/or treating major human diseases to improve human health.

The 2017 Tang Prize Award recipient, Dr. Feng Zhang, will present this year’s lecture. Dr. Zhang is an investigator at the McGovern Institute for Brain Research, core member of the Broad Institute of MIT and Harvard, and associate professor at MIT. He is a bioengineer with interests in developing tools for investigating neuroscience and human diseases. His previous work led to the development of “optogenetics” technology for regenerating nerve cells. His critical role in CRISPR technology was the first adaptation and demonstration in mammalian cells.

For more information, visit: http://experimentalbiology.org/2018/Program/Tang-Prize-Award-Lecture.aspx